Abstract The bone morphogenetic protein BMP2 plays a crucial role in the formation and regeneration of bone and cartilage, which is critical for maintaining skeletal integrity and bone fracture repair. Because of its important role in osteogenic properties it has been commercially produced for clinical use. Here we report attempts to express human BMP2 using two plant systems (lettuce chloroplast and soybean seeds). The rhBMP2 gene (coding for the 13 kDa active polypeptide) was introduced in two regions of the lettuce chloroplast genome. Two homoplasmic events were achieved and RT-PCR demonstrated that the BMP2 gene was transcribed. However, it was not possible to detect accumulation of rhBMP2 in leaves. Two soybean events were achieved to express a fulllength hBMP2 gene (coding for the 45 kDa pro-BMP2) fused with the a-coixin signal peptide, under control of the b-conglycinin promoter. Pro-BMP2 was expressed in the transgenic seeds at levels of up to 9.28% of the total soluble seed protein as determined by ELISA. It was demonstrated that this recombinant form was biologically active upon administration to C2C12 cell cultures, because it was able to induce an osteogenic cascade, as observed by the enhanced expression of SP7 (osterix) and ALPI (alkaline phosphatase) genes. Collectively, these results corroborated our previous observation that soybean seeds provide an effective strategy for achieving stable accumulation of functional therapeutic proteins, such as BMP2.
Introduction
Bone morphogenetic proteins (BMPs) were first described in 1965 by Marshall Urist as bone matrix components involved in the formation and regeneration of bone and cartilage (Urist 1965) . They can be found acting in many tissues, influencing embryonic development to chemotaxis, tooth morphogenesis, cell proliferation and differentiation (Carreira et al. 2014a ). More than 22 types of human BMPs have been described in humans, most notably BMP2, which is commercially produced in bacteria and mammal cells for clinical use because of its osteogenic properties (Brazil et al. 2015) . BMP2 plays a crucial role in inducing endochondral/intramembranous ossification and chondrogenesis through differentiation of mesenchymal stem cells to the osteoblastic lineage. This is a critical process for maintaining skeletal integrity and bone fracture repair (Carreira et al. 2014b) .
Studies using BMP2 knockout in mice demonstrated that lack of BMP2 seemed to block first bone fracture healing steps (Tsuji et al. 2006 ). 5 to 30% of patients suffering from bone fractures will tend to develop complications in bone healing causing nonunion or delayed union of the fractures (LissenbergThunnissen et al. 2011 ). The 13 kDa-recombinant BMP2 protein (rhBMP2) was FDA-approved for clinical use in cases of tibial fractures, certain types of oral maxillofacial interventions, and for spinal fusion. Current production systems use the recombinant form (rhBMP2) mainly produced in Chinese hamster ovarian (CHO) cells and Escherichia coli (Bessho et al. 2000) . BMP2 expression was achieved in many recombinant systems, including E. coli, Baculovirus/insect cells and mammalian cells (Fu et al. 2015; Maruoka et al. 1995; Wang et al. 1990 ). However, these production systems are expensive and non-scalable, so they cannot reach a higher demand of patients (Walsh 2014) . In addition, the 45-kDa pro-BMP2 was also expressed in E. coli. It was demonstrated that pro-BMP2 was functional as it induced the alkaline phosphatase (a marker enzyme for osteoblastic differentiation) in C2C12 cells (von Einem et al. 2011) , since both rhBMP2 and pro-BMP2 became internalized into C2C12 cells and pro-BMP2 was processed to mature BMP2 (von Einem et al. 2011) .
Plants can be used as an alternative platform to produce biopharmaceutical proteins on an agricultural scale. They have been successfully proved to offer support for the expression of a wide variety of human recombinant proteins (Staub et al. 2000; Leelavathi and Reddy 2003; Ma et al. 2003; Arlen et al. 2007; Farran et al. 2008; Nadai et al. 2009; Verma et al. 2010; Lim et al. 2011; Su et al. 2015; Wang et al. 2015) . It is a simple system that does not present common drawbacks of bacteria or mammalian cell culture, such as high cost of fermenters and risk associated with the potential occurrence of human pathogens (Ma et al. 2003; De Martinis et al. 2016) .
A challenge for all recombinant protein production systems is that expression levels are dependent on the protein (Daniell et al. 2010) . Chloroplasts proved to offer support for the expression of several human proteins (Oey et al. 2009; Nadai et al. 2009; Boyhan and Daniell 2011; Yarbakht et al. 2015) . The use of chloroplast technology for expression is facilitated by [ 10,000 copies of transgene per transplastomic cell. Another advantage is that plastid DNA is absent in pollens of most crops, avoiding foreign gene escape to the environment (Ahmad et al. 2016) . Cellular compartmentalization of the products minimizes pleiotropic effects, favoring stability and biosafety in the production (Zhang et al. 2017) . Lettuce concentrates a high number of chloroplasts in its leaves. Additionally, lettuce grows quickly under greenhouse conditions, producing a high amount of green mass, which makes it a promising vehicle for biopharmaceutical production, and it has been successfully used as a plant platform to produce therapeutic human proteins through plastid transformation (Kanamoto et al. 2006) .
Systems involving protein accumulation in seeds are other tools that offer the possibility of high protein production and long-term storage, which facilitates processing (Boothe et al. 2010 ). Concerns about protein stability are minimized by targeting the endoplasmic reticulum or seed storage vacuoles. Soybeans have storage vacuoles that are capable of accumulating high levels of proteins, which have already been used to produce biopharmaceutical molecules (Cunha et al. 2010 (Cunha et al. , 2011a Vianna et al. 2011) . BMP2 fused to other proteins has been expressed in plants. Suo et al. (2006) have expressed an hBMP2 fused with b-glucuronidase in tobacco plants obtaining 0.02% of purified BMP2 from the total soluble protein. Ceresoli et al. (2016) have expressed complete coding sequence of hBMP2 and the BMP2 C-terminal active domain fused to the N-Terminal of 27 kDa maize c-zein. The fused version accumulated up to 1% of total soluble leaf proteins.
Here, we report the evaluation of two systems for stable expression of biologically active recombinant human BMP2 molecules. We have evaluated the expression of the 13 kDa rhBMP2 in leaves of lettuce (Lactuca sativa) (via chloroplast genome transformation) and the 45 kDa pro-BMP2 in seeds of soybean (Glycine max) (via nuclear transformation). Protein extracts were evaluated for biological activity using established assays with cell lines sensitive to BMP2 (Lee et al. 2003) . Cotyledonary soybean tissues were demonstrated to be a suitable host for the BMP2 in terms of protein bioactivity and expression level.
Materials and methods

Lettuce chloroplast transformation
Chloroplast transformation of lettuce (cv. Verônica) was carried out according to Maldaner et al. (2013) using the plasmid vectors pCLLs-BMP2 and pLsCLORO-BMP2 (Fig. 1) . After shoot regeneration, leaf disks from elongated transgenic plantlets were used for de novo regeneration on the selective media Fig. 1 The pCLLs-BMP2 vector was based on the vector pRL1001 described by Kanamoto et al. (2006) . The pRL1001 vector contains the lettuce plastid rbcL (Genbank accession DQ383816; position 55039-56678) and accD (position 56695-57748) intergenic regions as a targeting site for homologous recombination, an aadA cassette (tobacco rrn promoteraadA-tobacco psbA terminator, which confers tolerance to spectinomycin, used to select transgenic plants) and a gfp expression cassette (tobacco psbA promoter-gfp coding sequence-tobacco rps16 terminator). The gfp was replaced by the hBMP2 coding sequence (GenBank accession ABR20911.1) between the sites for SphI and XbaI. The hBMP2 coding sequence was synthesized according to the L. sativa chloroplast codon usage. The pLsCLOROBMP2 vector contains the aadA and hBMP2 (in which the PpsbA from tobacco was replaced by the promoter LsPpsbA from lettuce) cassettes. The trnA-UGC-23S rRNA (Genbank accession DQ383816; position 103005-105141) and 16S rRNA-tRNA-Ile (position 100942-103004) are lettuce plastid intergenic regions, as a targeting site for homologous recombination. The pBMP2ahas vector contains the ps-hBMP2 (BMP2 fused to the signal peptide of the alpha coixin 6 from Coix lacryma-jobi) under control of the beta-conglycinin storage protein gene (bcsp5; GenBank accession M13759; position 1607-2448) and terminator (bcsp3; GenBank accession AB610665; position 2969-3401) from Glycine max. The cassette ahas5-ahascs-ahas3 is the mutated ahas gene from Arabidopsis thaliana, that confers tolerance to imazapyr, which was used to select transgenic plants (100 mg/L spectinomycin) until homoplasmic plants were obtained. Then the plantlets were transferred to soil to set seeds and further analysis.
The pCLLs-BMP2 vector was based on the vector pRL1001 described by Kanamoto et al. (2006) . The pRL1001 vector contains the lettuce plastid rbcL (Genbank accession DQ383816; position 55039-56678) and accD (position 56695-57748) intergenic regions as a targeting site for homologous recombination, an aadA cassette (which confers tolerance to spectinomycin, used to select transgenic plants) and a gfp expression cassette. The gfp was replaced by the hBMP2 coding sequence (GenBank accession ABR20911.1) between the sites for SphI and XbaI. The rhBMP2 coding sequence was synthesized according to the L. sativa chloroplast codon usage. The pLsCLORO-BMP2 contains the lettuce plastid trnA-UGC-23S rRNA (Genbank accession DQ383816; position 103005-105141) and 16S rRNAtRNA-Ile (position 100942-103004) intergenic regions as a targeting site for homologous recombination, an aadA cassette, the rhBMP2 sequence under control of the lettuce psbA promoter (LsPpsbA) and terminator (LsTpsbA). The rhBMP2 sequence was synthesized according to the L. sativa chloroplast codon usage. Vectors were synthesized at Epoch Inc. (USA).
Soybean transformation
Soybean transformation (cv BRS16) was carried out according to Aragão et al. (2000) using the plasmid vector pBMP2ahas (Fig. 1) . For the pBMP2ahas generation, the full-length hBMP2 (coding for the 45 kDa pro-BMP2) sequence was fused to the signal peptide of the alpha coixin 6 from Coix lacryma-jobi (GenBank accession KF475763; position 71-133), under control of the beta-conglycinin storage protein gene (alpha'-bcsp) promoter (bcsp5 0 ; GenBank accession M13759; position 1607-2448) and terminator (bcsp3 0 ; GenBank accession AB610665; position 2969-3401) from Glycine max. The hBMP2 expression cassette was cloned into the pAC32 vector (Rech et al. 2008) , which contains the mutated ahas gene that confers tolerance to imazapyr, which was used to select transgenic plants.
PCR analysis of transgenic lines DNA extraction and PCR were conducted according to SIGMA Extract N-Amp TM Plant PCR kits. Reactions were carried out according to Maldaner et al. (2013) . Lettuce plants transformed with the pLsCLORO-BMP2 vector were analyzed with the primer pair pCLOROF (TGAAAATTCGTGCGCTTGGG)/ pCLOROR (AATACCGAGCACTTCGCCAA) to amplify 914 bp within the rhBMP2 cassette. Lettuce plants transformed with the pCLLs-BMP2 vector were analyzed with the primer pair BMPCLF (GGATTGT TGCTCCTCCTGGAT)/Trps16R (GAATTTCAAGC TTCGGAAGGGCG) to amplify 309 bp within the hBMP2 cassette. Transgenic soybean plants were analyzed with the primer pair SOJAMATF (CCGGGG TATCACGCCTTTTA)/SOJAMATR (CCACAACC CTCCACAACCAT) to amplify 264 bp within the hBMP2 cassette.
Analysis of homoplastomic state of lettuce lines
Southern blot analyses were carried out to determine the homoplasmic status of the de novo regenerated transplastomic lettuce plants. Total DNA was isolated using CTAB method, and Southern blot was carried out as described by Lacorte et al. (2010) . Chloroplast DNA (20 lg) was digested with BalI (for plants transformed with pLsCLOROBMP2 vector) and XbaI (for plants transformed with pCLLsBMP2 vector). For pCLLsBMP2-plants probe a was used (Fig. 1) . Probe a corresponds to a 500-bp fragment from rbcL gene and was generated by PCR with the primer pair rbcLF (GGACGCGATCTTGCTACTGA)/rbcLR (TGCATGTTGGATTCGGCTCA) according to Maldaner et al. (2013) . For pLsCLOROBMP2-plants probe b was used (within the trna-UGC-23S rRNA region (Fig. 1) . Probe b (379 bp) was generated by PCR (as described above) using the primer pair clLsrRNAF (CACCGTAAGCCTTTCCTCGT) and clLsrRNAR (TGGGATTCCAACTCAGCACC).
BMP2 expression analysis in lettuce lines
RT-PCR was used to detect transcripts corresponding to the hBMP2 gene. Total RNA was extracted from lettuce leaves using the Ambion (Thermo Fischer) kit following manufacturer's instructions. RNA samples (100 ng) were used as the template for reverse-transcriptase coupled PCR following Superscript III one step (Invitrogen) following the kit instructions, using the primer pair BMPCLF (GGATTGTTGCTC CTCCTGGAT)/BMPCLR (TCCACATCCTTCAAC AACCAT) to amplify a 245 bp fragment from the rhBMP2 gene. As an internal control, primers rbcLF (GGACGCGATCTTGCTACTGA)/rbcLR (TGCAT GTTGGATTCGGCTCA) were utilized to amplify 213 bp within the chloroplast rbcL (Rubisco) gene.
Immunoblot analysis
Total proteins were extracted from transgenic lettuce leaves and soybean seeds according to Maldaner et al. (2013) and Cunha et al. (2010) , respectively. Protein extracts were filtered using a 0.45 lm syringe filter and quantified using the Quick Start Bradford Protein Assay (Bio-Rad Laboratories, Inc., USA).
For western blotting, samples were incubated with 1:1 v/v loading buffer (20% sodium dodecyl sulfate (SDS), 0.5 M Tris-HCl, 10% b-mercaptoethanol, 20% glycerol, 0.04% bromophenol blue) at 95°C for 5 min and separated in a polyacrilamide gel (4% stacking gel and 12% resolving gel). Proteins were transferred to a PVDF (polvvynilidene difluoride) membrane for 60 min, 24 V. The membranes were blocked with 30 mL of blocking solution [5% non-fat milk in TBS (0.02 M Tris base and 0.137 M NaCl, pH 7.6)] for 16 h at 4°C and washed three times with TBST buffer (TBS with tween 0.1%, pH 7.6).
For lettuce protein analysis, membranes were incubated with specific mouse anti-BMP2 monoclonal antibody (10R-7775, Fitzgerald Industries International, USA) diluted in 1% non-fat milk dissolved with TBS (1:1000) for 16hs at 4°C. Then, membranes were washed three times with TBST, incubated with 1:10,000 rabbit anti-mouse IgG anti-serum conjugated with alkaline phosphatase (Sigma Aldrich, USA) for 2 h and developed in NBT/BCIP substrate solution for 15 min at room temperature. For soybean protein analysis, membranes were incubated with specific goat anti-BMP2 IgG polyclonal antibody (Santa Cruz Biotechnology, USA) diluted in 1% non-fat milk dissolved with TBS (1:2000) for 16 h at 4°C. Then, membranes were washed three times with TBST, incubated with 1: 5000 rabbit anti-goat IgG anti-serum conjugated with alkaline phosphatase (Santa Cruz Biotechnology, USA) for 2 h and developed in NBT/ BCIP substrate solution for 15 min at room temperature.
Quantification of hBMP2 in soybean transgenic seeds
The BMP2 quantification was carried out using the Quantikine TM Human BMP-2 Immunoassay (R&D Systems, Inc., USA) according to the manufacturer's protocol. Result was expressed as percentage of BMP2 of total soluble protein (TSP).
BMP2 biological activity assay
Biological activity of plant produced-hBMP2 was carried out in C2C12 cells (immortalized mouse myoblast cell line). Cells were cultivated at 37°C under 5% CO 2 atmosphere in T-75 flasks (Falcon TM ) containing growth medium [Dulbecco's Modified Eagle's Minimum Essential Medium (DMEM, Gibco)] supplemented with 10% fetal bovine serum and 100 units/mL penicillin/streptomycin (Life technologies, USA). After reaching 80% confluence they were transferred to 24-well plates for enzymatic assays, using a density of 2 9 10 4 C2C12 cells per well.
After 24 h of incubation, 25 lg of total protein isolated from soybean lines (containing 2.3 lg of pro-BMP2) or 50 ng/mL commercial rhBMP-2 (25 ng; positive control, previously established as the minimal amount that induced osteogenesis) was added to the plated C2C12 cells. Cells cultivated on growth medium were used as negative control (blank).
RT-qPCR was carried out to measure the expression levels of SP7 (Osterix) and ALPI genes, which are related to the osteogenesis cascade activation. Total RNA from C2C12 cells was extracted using Trizol (Invitrogen) as recommended by the manufacturer and digested with DNase I RNase free (Qiagen, Valencia, CA, USA) to remove DNA contamination. cDNA was generated using the iScript advanced cDNA synthesis kit (BioRad) according to manufacturer's instructions. RT-qPCR was performed according Mendonça et al. (2013) using the Real-Time PCR System 7500 (Applied Biosystems). To confirm the amplification specificity, the PCR products were subjected to an analysis of the dissociation curve. The threshold cycles (Ct) of each reaction were normalized to those obtained for the gapdh housekeeping gene using the -DD Ct method (Livak 2001) . All PCR reactions were performed in triplicate.
Statistics
Data were expressed as the mean ± SEM of at least three independent experiments. Differences were considered statistically significant with P values of \ 0.05 using two-way ANOVA/Tukey's multiple range tests. The GraphPad Prism Software (version 6.02) was used.
Results
Transplastomic lettuce plants
One transplastomic lettuce event was obtained using each of the pCLLs-BMP2 and pLsCLORO-BMP2 vectors, named as ALF1 and ALF2 respectively. PCR analysis confirmed the presence of the hBMP2 gene (Fig. 2) .
After shoot regeneration, leaf disks from elongated transgenic plantlets were used for de novo regeneration on the selective media supplemented with spectinomycin to achieve homoplasmic plants. Southern blot analyses revealed that both transgenic lines showing that the transgenes were inserted into the chloroplast genome differentiating non-transgenic (1, presence of the 7.7 kb and 16.5 kb bands) heteroplasmic (2, presence of the 7.7 kb, 10 kb, 16.5 kb and 18.8 kb bands) and homoplasmic (3, presence of the 10 kb and 18.8 kb bands) plants. The presence of the 10 kb and 18.8 in the line ALF2 demonstrated that the transgenes were inserted twice into chloroplast genome (ALF1 and ALF2) were stably transformed. Results have shown that both ALF1 and ALF2 lines were homoplasmic, as the 7.7 kb and 16.5 kb fragment in the pLsCLORO-BMP2-transformed plants and the 5 kb fragment in the pCLLs-BMP2-transformed plants were not observed (Fig. 2) . These fragments were only observed in the wild type (non-transformed) lines. In addition, these results demonstrated that the transgene cassette was introduced twice in the repetitive region of the ALF2 event (Fig. 2) .
RT-PCR was carried out to detect the rhBMP2 transcripts in the transplastomic lettuce lines. Results revealed the presence of rhBMP2 transcripts in both ALF1 and ALF2 lines (Fig. 3) . However, it was not possible to clearly detect the rhBMP2 protein in western blot analyses in both ALF1 and ALF2 lines (Fig. 3) .
BMP2 expression in transgenic soybean seeds
Two transgenic soybean lines were achieved and named SOY7 and SOY11. PCR analyses confirmed the presence of the hBMP2 transgene in both lines (Fig. 4) . Western blot analyses using polyclonal antibody specific for human BMP2 were carried out to detect the BMP2 protein in total protein extract from soybean seeds. Results revealed the presence of the hBMP2 protein (the expected 45 kDa band) only in the SOY7 line, which could be also visualized on the SDS-PAGE stained with coomassie blue (Fig. 4b) . The quantitative sandwich enzyme immunoassay SDS-PAGE of total seed proteins (25 lg) stained with coomassie blue in on the left. The white arrow shows the hBMP2 position. Control: non-transgenic plant. c Solid-phase ELISA performed using the Quantikine Human BMP-2 Immunoassay to detect and quantify the pro-BMP2 in soybean seeds (line SOY7). Control: non-transgenic seeds. Asterisk represents significant difference compared to control (P \ 0.01, n = 3) technique revealed that the BMP2 protein was expressed in the transgenic seeds of the SOY7 at levels of up to 9.28% of the total soluble seed protein (Fig. 4c) .
BMP2 activity in C2C12 cells
In order to demonstrate bioactivity, proteins isolated from soybean seeds were added to the medium where C2C12 cells are being cultivated. After two and 4 days, the expression of two genes, which are induced by the presence of BMP2 (SP7 and ALPI), was quantified by RT-qPCR (Fig. 5) . Results for the SOY7 soybean line showed a significant increased expression of SP7 and ALPl. SP7 presented a 6.6-and 7.8-fold up-regulation. ALPl increased by fourfold at day 2 but showed slight reduction to 3.2-fold at day 4. Proteins isolated from soybean seeds and delivered to the C2C12 cells had a similar effect compared to cells treated with rhBMP2 protein (Fig. 5) .
Discussion
Heterologous protein expression in plant systems has attractive features; it can be considered safer due to the absence of human pathogens and more efficient due to the possibility if obtaining high numbers of functional molecules (Ma et al. 2003) . Novel systems for therapeutic protein production have been studied, cells incubated for 2 and 4 days with proteins isolated from soybean seeds (line SOY 7 expressing the BMP2), 0 ng/mL (blank) and 50 ng/mL BMP2. Data were represented as the fold change relative to the control (non-transgenic soybean) which was made equal to 1.0. Normalization of data was performed with GAPDH. Data represent average ± SE, n = 3 biological replicates. Asterisks represent significant statistical differences compared to control (GAPDH) (P \ 0.05) aiming to produce larger quantities of valuable molecules with reduced cost (Lomonossoff and D'Aoust 2016) .
BMP2 is associated with various processes during bone regeneration, being an important factor that drives the first steps of bone healing. In this study, two plant systems were evaluated for BMP2 production. Stable soybean transformation to express a full-length hBMP2 gene was demonstrated to be more suitable for producing a biologically active protein.
Two transplastomic lettuce lines were obtained, with the insertion of the transgenes in two regions of the chloroplast genome. In one line, two copies of the transgenes were inserted into the repetitive regions of the genome. We used a pRL1001-based vector to insert the transgenes in the intergenic region between rbcL and accD (Kanamoto et al. 2006) . Vectors based on this strategy have been used to efficiently express Interferon-c, a bacterial lipoprotein (OspA), and transcription growth factor b-3 in tobacco chloroplasts (Leelavathi and Reddy 2003; Glenz et al. 2006; Gisby et al. 2011) , Human Thioredoxin 1 and Human Granulocyte Colony-Stimulating factor in lettuce chloroplasts (Lim et al. 2011; Tabar et al. 2013) . We have previously used a pRL1001-based vector to produce large amounts of a functional 12.1 kDapeptide corresponding to epitopes from dengue virus protein E (Maldaner et al. 2013 ). Here we also tested a novel vector to insert the transgenes twice into the repetitive region, between tRNA-Ile and trnaA-UGC. There are reports showing efficient expression of recombinant therapeutic proteins with the insertion of the transgenes between tRNA-Ile and trnaA-UGC in the chloroplast genome of lettuce and tobacco, for producing vaccine antigens against cholera and malaria, Human Papillomavirus L1 protein and bioencapsulated Factor IX (Fernández-San Millán et al. 2008; Davoodi-Semiromi et al. 2010; Su et al. 2015) . Krichevsky et al. (2010) achieved 25 times more luciferase (lux) with the transgene inserted in this region, when compared with the insertion in other regions, such as transcriptionally-silent spacer region (Maliga concept) (Jin and Daniell 2015) . In this work, we generated transgenic homoplasmic plants to express BMP2 in both transcriptionally-silent and active spacer (Daniell concept) regions. Nevertheless, it was not possible to observe detectable quantities of BMP2 in leaves of plants transformed with both Maliga and Daniell concepts (Jin and Daniell 2015) .
However, the results indicated the presence of steadystate mRNA, suggesting that genes are being correctly transcribed. The absence of detectable amounts of BMP2 could be related to protein instability or degradation. Similarly, Lelivelt et al. (2005) attempted to express an immunogenic protein against the influenza virus in lettuce chloroplast, and the heterologous protein was also not identified, although northern blot analyses demonstrated the expression of the transgene. Elghabi et al. (2011) failed to express Cyanovirin-N in chloroplast of tobacco. However, after the fusion of Cyanovirin-N with GFP and Ply, at the N-terminus, it was possible to achieve 0.3% total soluble protein using Cyanovirin-GFP. It has been suggested that several key factors could influence correct accumulation of therapeutic recombinant protein in chloroplasts, such as instability related to the N-terminus, improper folding and internal sequence (Apel et al. 2010; De Marchis et al. 2012; Bock 2014) . Some of these factors could be associated with poor accumulations of BMP2 in lettuce and should be further studied.
Seeds of several plant species have been used to produce pharmaceutical proteins, such as Arabidopsis, rice and corn (Stoger et al. 2005; Boothe et al. 2010) . The main advantages of these systems include larger amounts of accumulated proteins, lower protease content, stability and long-term storage of recombinant proteins (Stoger et al. 2005) . As an alternative for accumulation of BMP2 in plants, we evaluated the soybean seed system. We have previously used soybean seeds as a vehicle for producing bioactive human growth hormone (2.9% TSP) and factor IX (0.23% TSP) with genes under control of the bconglycinin promoter and addition of the a-coixin signal peptide (Cunha et al. 2011a, b) .
BMP2 was expressed in tobacco leaves as the complete coding sequence or fused with b-glucuronidase and maize c-zein (Ceresoli et al. 2016; Suo et al. 2006 ) accumulating from 0.02 to 1% of the total soluble protein. Here we have observed that the soybean line SOY7 accumulated Pro-BMP2 up to 9.28% TSP suggesting that it could be a better system for recombinant BMP2 production in plants. In addition, we have demonstrated that the Pro-BMP2 produced in soybean seed was functional. C2C12 cells are immortalized lineage of mouse myoblast cells, which are highly responsive to BMP2 and can transdifferentiate to osteoblastic cells. These cells produce a very strong ALPl activity in response to Pro-BMP2 compared to control growth medium (Lee et al. 2014) . The difference in fold change between the soybean extracts and rhBMP2 could be related to the fact that the protein in the soybean extract was not purified and this reduced the amount of BMP2 effectively delivered to the cells. Furthermore, the activity is probably due to proteolytic maturation generating the active form after endocytosis, a relatively slow and not fully efficient process (Von Einem et al. 2011) . Before expressing ALPl, the cells have to express the SP7 transcription factor to start differentiation into osteoblastic lineage (Sondag et al. 2014) . Transgene expression has been stable for at least four generations of homozygous plants (data not shown), corroborating our previous observation that soybean seeds provide an effective system for achieving stable accumulation of functional therapeutic proteins.
